المؤلفون: Maunula, A., Atula, S., Laakso, S. M., Tienari, P. J.

المساهمون: TRIMM - Translational Immunology Research Program, HUS Neurocenter, Neurologian yksikkö, Department of Neurosciences, Clinicum

مصطلحات موضوعية: Fingolimod, Lymphopenia, Multiple sclerosis, Rebound, Relapse, Neurosciences, Neurology and psychiatry

وصف الملف: application/pdf

Relation: This work was supported by Research Funding of the State of Finland governed through Helsinki University Hospital (grant numbers TYH2019258, TYH2021233, TYH2022227, Y2112NEURO) and governed through Hyvinkää Hospital (grant numbers M3080TUT22, M3080TUT21), Academy of Finland (grant number 332186). The authors acknowledge the continuous work of improving the MS register by StellarQ Ltd and MS register steering committee. This work was supported by Research Funding of the State of Finland governed through Helsinki University Hospital (grant numbers TYH2019258 , TYH2021233 , TYH2022227 , Y2112NEURO ) and governed through Hyvinkää Hospital (grant numbers M3080TUT22 , M3080TUT21 ), Academy of Finland (grant number 332186 ).; This work was supported by Research Funding of the State of Finland governed through Helsinki University Hospital (grant numbers TYH2019258, TYH2021233, TYH2022227, Y2112NEURO) and governed through Hyvinkaa Hospital (grant numbers M3080TUT22, M3080TUT21) , Academy of Finland (grant number 332186) .; Maunula , A , Atula , S , Laakso , S M & Tienari , P J 2024 , ' Frequency and risk factors of rebound after fingolimod discontinuation – A retrospective study ' , Multiple sclerosis and related disorders , vol. 81 , 105134 . https://doi.org/10.1016/j.msard.2023.105134; ORCID: /0000-0002-0104-2849/work/150785704; http://hdl.handle.net/10138/568697; baec2851-1682-4117-a587-2db2cc1df05c; 85177605194; 001116586000001

الاتاحة: http://hdl.handle.net/10138/568697

المؤلفون: Hänninen, K., Viitala, M., Atula, S., Laakso, S. M., Kuusisto, H., Soilu-Hänninen, M.

المساهمون: HUS Neurocenter, Neurologian yksikkö

مصطلحات موضوعية: Multiple sclerosis, DMT, EDSS, Treatment, Strategy, Disability, MULTIPLE-SCLEROSIS, INTERFERON-BETA, PROGRESSION, EFFICACY, THERAPY, EUROPE, ONSET, TIME, Neurosciences, Neurology and psychiatry

وصف الملف: application/pdf

Relation: Open access funding provided by University of Turku (UTU) including Turku University Central Hospital. K Hanninen received personal research grants from the Finnish Multiple Sclerosis Foundation, Turku University Foundation and Turku University State Research Funding.; Hänninen , K , Viitala , M , Atula , S , Laakso , S M , Kuusisto , H & Soilu-Hänninen , M 2022 , ' Initial treatment strategy and clinical outcomes in Finnish MS patients : a propensity-matched study ' , Journal of Neurology , vol. 269 , no. 2 , pp. 913-922 . https://doi.org/10.1007/s00415-021-10673-9; ORCID: /0000-0002-0104-2849/work/117944445; http://hdl.handle.net/10138/347216; e99a096c-190f-44b2-be91-96ff72600b67; 000666891600001

الاتاحة: http://hdl.handle.net/10138/347216

المؤلفون: Hänninen, K., Viitala, M., Atula, S., Laakso, S. M., Kuusisto, H., Soilu-Hänninen, M.

المساهمون: Tampere University, Kanta-Häme Central Hospital Hämeenlinna, Department of Neurosciences and Rehabilitation

مصطلحات موضوعية: 3112 Neurosciences

وصف الملف: fulltext

Relation: JOURNAL OF NEUROLOGY; https://trepo.tuni.fi/handle/10024/133454; URN:NBN:fi:tuni-202107236327

الاتاحة: https://trepo.tuni.fi/handle/10024/133454
https://doi.org/10.1007/s00415-021-10673-9

المؤلفون: Koivula, T.‐T.^1,2, Laakso, S. M.^1,2, Niemi, H. J.^1,2, Kekäläinen, E.^1,2,3, Laine, P.⁴, Paulin, L.⁴, Auvinen, P.⁴, Arstila, T. P.^1,2 petteri.arstila@helsinki.fi

المصدر: Scandinavian Journal of Immunology. Oct2017, Vol. 86 Issue 4, p221-228. 8p.

مصطلحات موضوعية: *REGULATOR genes, *GENETIC mutation, *AUTOIMMUNE polyendocrinopathies, *T cells, *CLONE cells, *PHYSIOLOGY